Strength
300 mg/1
Manufacturer
AvPAKNDC
50268004912
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ABACAVIR SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA091560On Market Since
4/10/2020
Pharmacological Classes
Price Statistics
The NADAC for ABACAVIR 300 MG TABLET has been published 302 times since Sep 16, 2020, and over the history we have for it it has declined 32.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6012 per EA |
|---|---|
| All-time high | $0.8884 (Sep 16, 2020) |
| All-time low | $0.4392 (Dec 22, 2021) |
| 52-week high | $0.6820 |
| 52-week low | $0.6012 |
| Median price | $0.6410 |
| Average price | $0.6470 |
| Largest weekly change | +59.4% (Feb 23, 2022) |
| Weeks tracked | 302 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABACAVIR 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABACAVIR 300 MG TABLET, manufactured by AvPAK, is $0.6012 per EA (NDC 50268004912), effective Jun 24, 2026.
How has the price of ABACAVIR 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABACAVIR 300 MG TABLET has declined 32.3%. It has been tracked across 302 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for ABACAVIR 300 MG TABLET?
Since Sep 16, 2020, the NADAC for ABACAVIR 300 MG TABLET has ranged from a low of $0.4392 (Dec 22, 2021) to a high of $0.8884 (Sep 16, 2020), with a median of $0.6410 per EA.
Are there cheaper alternatives to ABACAVIR 300 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as ABACAVIR 300 MG TABLET, but none are currently priced below it.
Who manufactures ABACAVIR 300 MG TABLET?
ABACAVIR 300 MG TABLET (NDC 50268004912) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification